CRSP
Price
$43.33
Change
-$2.20 (-4.83%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
3.72B
62 days until earnings call
INCY
Price
$71.14
Change
+$0.35 (+0.49%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
13.77B
56 days until earnings call
Ad is loading...

CRSP vs INCY

Header iconCRSP vs INCY Comparison
Open Charts CRSP vs INCYBanner chart's image
CRISPR Therapeutics AG
Price$43.33
Change-$2.20 (-4.83%)
Volume$46.59K
Capitalization3.72B
Incyte
Price$71.14
Change+$0.35 (+0.49%)
Volume$26.11K
Capitalization13.77B
CRSP vs INCY Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. INCY commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and INCY is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CRSP: $43.45 vs. INCY: $69.68)
Brand notoriety: CRSP: Not notable vs. INCY: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 92% vs. INCY: 170%
Market capitalization -- CRSP: $3.72B vs. INCY: $13.77B
CRSP [@Biotechnology] is valued at $3.72B. INCY’s [@Biotechnology] market capitalization is $13.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileINCY’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • INCY’s FA Score: 1 green, 4 red.
According to our system of comparison, INCY is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while INCY’s TA Score has 6 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 5 bearish.
  • INCY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, INCY is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -2.38% price change this week, while INCY (@Biotechnology) price change was -6.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

INCY is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY($13.8B) has a higher market cap than CRSP($3.72B). CRSP YTD gains are higher at: 10.391 vs. INCY (0.883). INCY has higher annual earnings (EBITDA): 408M vs. CRSP (-447.31M). INCY has more cash in the bank: 2.16B vs. CRSP (1.9B). INCY has less debt than CRSP: INCY (43.5M) vs CRSP (224M). INCY has higher revenues than CRSP: INCY (4.24B) vs CRSP (35M).
CRSPINCYCRSP / INCY
Capitalization3.72B13.8B27%
EBITDA-447.31M408M-110%
Gain YTD10.3910.8831,177%
P/E RatioN/A474.27-
Revenue35M4.24B1%
Total Cash1.9B2.16B88%
Total Debt224M43.5M515%
FUNDAMENTALS RATINGS
CRSP vs INCY: Fundamental Ratings
CRSP
INCY
OUTLOOK RATING
1..100
8173
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6352
P/E GROWTH RATING
1..100
781
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (69) in the Biotechnology industry is in the same range as INCY (95). This means that CRSP’s stock grew similarly to INCY’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INCY (100). This means that CRSP’s stock grew similarly to INCY’s over the last 12 months.

CRSP's SMR Rating (100) in the Biotechnology industry is in the same range as INCY (100). This means that CRSP’s stock grew similarly to INCY’s over the last 12 months.

INCY's Price Growth Rating (52) in the Biotechnology industry is in the same range as CRSP (63). This means that INCY’s stock grew similarly to CRSP’s over the last 12 months.

INCY's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CRSP (78). This means that INCY’s stock grew significantly faster than CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPINCY
RSI
ODDS (%)
Bearish Trend 7 days ago
82%
Bullish Trend 7 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
60%
Momentum
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
66%
MACD
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
79%
Bearish Trend 7 days ago
62%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 14 days ago
61%
Declines
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 7 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
81%
Bullish Trend 7 days ago
56%
Aroon
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
50%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+2.74%
BEAM - CRSP
70%
Closely correlated
+5.34%
RXRX - CRSP
65%
Loosely correlated
-1.82%
PRME - CRSP
64%
Loosely correlated
-1.34%
NTLA - CRSP
62%
Loosely correlated
-3.76%
ALLO - CRSP
58%
Loosely correlated
+5.56%
More

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with RPRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then RPRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
-0.83%
RPRX - INCY
37%
Loosely correlated
-1.59%
PLRX - INCY
36%
Loosely correlated
-2.17%
ZYME - INCY
33%
Loosely correlated
+0.08%
RVMD - INCY
33%
Loosely correlated
-0.99%
REGN - INCY
33%
Poorly correlated
-1.37%
More